2024
DOI: 10.1210/clinem/dgae023
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review

Douglas C Bauer,
Dennis M Black,
Rick Dell
et al.

Abstract: Context Prolonged bisphosphonate (BP) treatment for osteoporosis prevents hip and other fractures but causes atypical femoral fractures (AFF). Objective To establish the relationship between patterns of BP use and the risk of AFF and hip fractures. Other potential risk factors for AFF were also examined. Design Population-based case-cohort study … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
5
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 35 publications
1
5
0
Order By: Relevance
“…Although BP use, specifically prolonged exposure, increases the risk of AFF, the beneficial effects of BP therapy in adults more than 50 dramatically outweigh this increased risk where the ratio of reduced hip fracture to increased AFF risk favors BP treatment in a Danish study. 22 Similar to our study, almost one-third of those with AFF had no BP exposure and other risk factors may be the cause. 22 In addition, discontinuation of BPs leads to a decrease in AFF risk.…”
Section: Discussionsupporting
confidence: 87%
See 4 more Smart Citations
“…Although BP use, specifically prolonged exposure, increases the risk of AFF, the beneficial effects of BP therapy in adults more than 50 dramatically outweigh this increased risk where the ratio of reduced hip fracture to increased AFF risk favors BP treatment in a Danish study. 22 Similar to our study, almost one-third of those with AFF had no BP exposure and other risk factors may be the cause. 22 In addition, discontinuation of BPs leads to a decrease in AFF risk.…”
Section: Discussionsupporting
confidence: 87%
“… 10 Interestingly, exposure to BP in the AFF population was smaller when compared with 3 other large US and European population-based studies in which 90.5%, 78%, and 69% of AFF patients had evidence of previous BP or Dmab use and a smaller UK study where 70% of AFF patients were previously exposed to BP. 16 , 17 , 22 , 24 However, 3 smaller studies in South Korea and Thailand found a smaller proportion of AFF patients, ranging from 35.3% to 44.4%, with previous exposure to BPs. 14 , 18 , 25 This could be explained by different populations having different baseline risks for AFF, with more at-risk populations having AFFs with less exposure to BP.…”
Section: Discussionmentioning
confidence: 96%
See 3 more Smart Citations